Gts Securities LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $807,534 - $1.1 Million	-11,700 Reduced 17.92%	53,600 $3.77 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $1.12 Million - $1.38 Million	15,000 Added 29.82%	65,300 $5.38 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $1.06 Million - $1.26 Million	12,700 Added 33.78%	50,300 $4.39 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $1.28 Million - $1.65 Million	16,800 Added 80.77%	37,600 $3.63 Million
Q3 2023 Nov 15, 2023	BUY	$85.07 - $94.48 $1.77 Million - $1.97 Million	20,800 New	20,800 $1.84 Million

638

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.